This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.


This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Onno Holleboom
A.G. Onno
Amsterdam UMC, Amsterdam, Netherlands

Dr. A.G. (Onno) Holleboom MD PhD is an internist registered in Vascular Medicine and Endocrinology, faculty member of the Department of Vascular Medicine and Assistant Professor at Amsterdam UMC. He heads a multidisciplinary outpatient clinic for NAFLD together with hepatology and including clinical trials. Within the NAFLD-NL consortium and supported by the Dutch MLDS gastroenterology and hepatology foundation, his team investigates and implements care paths for NAFLD together with LUMC and Radboud MC. He participates in LITMUS, will participate in the new Grip on NASH consortium, has co-authored the Dutch NAFLD-NASH guideline and is on the Delphi panel for the revised EASL-EASD-EASO guideline. Together with prof. Max Nieuwdorp, he runs a research group with 5 PhD candidates focussing on genetic and gut microbial drivers of NAFLD in three cohort studies, as well as more fundamental work on pathways around lipophagy and liver sinusoidal endothelium. He has published 73 peer-reviewed articles, including in Circulation and Cell Metabolism and received various prestigious grants, a.o. from The Netherlands Organization for Scientific Research and the Amsterdam UMC Fellowship.